Valsartan Recall Lawyer

OUR PHILOSOPHY

The Importance of a Lawyer You Can Trust.

On July 13, 2018, the U.S. Food and Drug Administration announced a voluntary recall of valsartan, a generic drug used to treat high blood pressure and congestive heart failure because it may contain a probable human carcinogen. The carcinogen, N-nitrosodimethylamine (NDMA), may have entered the product during manufacture in China and India.

If you or a loved one has taken this drug and has suffered from effects caused by the carcinogen, including cancer, tumors, or liver fibrosis/scarring, you should get in touch with the valsartan recall lawyers at Golden Law Office today. We may be able to help you recover.

According to the Environmental Protection Agency, NDMA is no longer produced in the United States, except for research purposes. It was formerly used in the production of rocket fuel, lubricants, and softeners for copolymers. NDMA is classified as a “potent carcinogen” and is not fit for human consumption.

The United States valsartan recall was issued after 22 other countries issued recalls involving 2,300 valsartan batches sent to Germany, Finland, Norway, Hungary, Sweden, Austria, the Netherlands, Ireland, Italy, Spain, Bulgaria, Belgium, France, Portugal, Poland, Lithuania, Croatia, Canada, Greece, Bosnia, Malta, Herzegovina, and Bahrain.

If it’s found that the drug indeed contained NDMA when manufactured, individuals who have suffered from the effects of the carcinogen may be eligible to receive compensation that can be used for the following:

• • Past and future medical expenses relating to necessary treatment

• • Loss of wages

• • Past and future pain and suffering relating to both physical and mental implications

• • Other economic losses experienced as a result of the injury

• • Potential punitive damages

To learn more about filing a potential lawsuit, keep reading or get in touch with our experienced and qualified attorneys as soon as possible.